Top in hem/onc: Gender pay gap in medicine; improvements in colorectal cancer survival
Click Here to Manage Email Alerts
Female physicians experienced a greater earnings penalty due in part to marriage and children compared with their male counterparts, according a recent study.
Researchers found that female physicians were more likely to be single and less likely to have children than their male counterparts, but still earned less per hour regardless. When female physicians do marry and have children, they experience a steeper earnings penalty because of less hours worked than men. It was the top story in hematology/oncology last week.
Another top story was about a study which found that survival for patients with metastatic colorectal cancer has improved overall. However, despite these improvements, the majority of patients died within 5 years of diagnosis, highlighting the need for further drug development.
Read these and more top stories in hematology/oncology below:
Female physicians experience greater earnings penalty due in part to marriage, children
Marriage and children appeared to be associated with a greater earnings penalty among female physicians because of less hours worked when compared with their male counterparts, according to study results published in JAMA Health Forum. Read more.
Survival in metastatic colorectal cancer has improved, but further drug development needed
Survival for patients with metastatic colorectal cancer has improved steadily since 2012, according to retrospective study results. Watch video.
Cancer vaccine research may have reached ‘tipping point’
The concept of cancer vaccination has generated excitement in the scientific community for decades. Read more.
Neighborhood factors may drive racial disparities in pediatric cancer outcomes
Survival for patients with metastatic colorectal cancer has improved steadily since 2012, according to retrospective study results. Read more.
Machine learning may guide use of neoadjuvant therapy for pancreatic cancer
Machine learning algorithms can help predict positive resection margin and lymph node metastases among patients with pancreatic ductal adenocarcinoma, according to study results. Read more.